175 results on '"Borch-Johnsen, K."'
Search Results
2. Cost‐effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen‐detected Type 2 diabetes: analysis of the ADDITION‐UK cluster‐randomized controlled trial
3. Variation in prescribing of lipid‐lowering medication in primary care is associated with incidence of cardiovascular disease and all‐cause mortality in people with screen‐detected diabetes: findings from theADDITION ‐Denmarktrial
4. General health checks may work
5. Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen‐detected diabetes? Results from the ADDITION‐Europe cluster randomized trial
6. The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status
7. Insulin resistance and beta-cell function in different ethnic groups in Kenya: the role of abdominal fat distribution
8. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study
9. Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen‐detected diabetes? Findings from the ADDITION‐Europe cluster‐randomized trial
10. Cardiorespiratory fitness and physical activity in Luo, Kamba, and Maasai of rural Kenya
11. Diabetes in Greenland and its relationship with urbanization
12. The immune marker soluble urokinase plasminogen activator receptor is associated with new‐onset diabetes in non‐smoking women and men
13. A globally applicable screening model for detecting individuals with undiagnosed diabetes
14. The effects of adding group-based lifestyle counselling to individual counselling on changes in plasma glucose levels in a randomized controlled trial: The Inter99 study
15. Screening for Type 2 diabetes. Lessons from the ADDITION-Europe study
16. Comparing incident diabetes as defined by fasting plasma glucose or by HbA1c. The AusDiab, Inter99 and DESIR studies
17. O3-3.2 Low vitamin D status and risk of type 2 diabetes: a prospective cohort study
18. HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark
19. Cumulative glycaemia as measured by lens fluorometry: association with retinopathy in type 2 diabetes
20. HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark
21. Impact of size at birth and prematurity on adult anthropometry in 4744 middle-aged Danes – The Inter99 study
22. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1cThe Danish Inter99 study
23. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
24. O94 La comparaison de la prédiction du diabète défini par la glycémie à jeun ou par l’HbA1c : AusDiab, Inter99 et D.E.S.I.R
25. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study
26. The rise and fall of the metabolic syndrome
27. Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin‐treated Type 2 diabetes
28. Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 Study
29. Diagnosing diabetes—time for a change?
30. A variant in the G6PC2/ABCB11 locus is associated with increased fasting plasma glucose, increased basal hepatic glucose production and increased insulin release after oral and intravenous glucose loads
31. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?
32. Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya
33. Socioeconomic factors related to attendance at a Type 2 diabetes screening programme
34. Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene–gene interaction
35. Five-year change in physical activity is associated with changes in cardiovascular disease risk factors
36. Predictors of future fasting and 2‐h post‐OGTT plasma glucose levels in middle‐aged men and women—the Inter99 study
37. Functional SOCS1 polymorphisms are associated with variation in obesity in whites
38. HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population
39. Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation
40. A cross-sectional study of the association between persistent organic pollutants and glucose intolerance among Greenland Inuit
41. Association of the β3-adrenergic receptor Trp64Arg polymorphism with common metabolic traits: Studies of 7605 middle-aged white people
42. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study
43. Short-term reproducibility of impaired fasting glycaemia, impaired glucose tolerance and diabetes
44. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action
45. Measurement of blood glucose: comparison between different types of specimens
46. Polymorphisms in AHI1 are not associated with type 2 diabetes or related phenotypes in Danes: non-replication of a genome-wide association result
47. EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
48. EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE .
49. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes
50. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.